nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
American Journal of Transplantation: Volume 22, Number 5, May 2022
|
|
|
|
22 |
5 |
p. i |
artikel |
2 |
A new VISTA on kidney fibrosis
|
Li, Xian C. |
|
|
22 |
5 |
p. 1287 |
artikel |
3 |
Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients
|
Kamar, Nassim |
|
|
22 |
5 |
p. 1467-1474 |
artikel |
4 |
Applying the ethical framework for donation after circulatory death to thoracic normothermic regional perfusion procedures
|
Wall, Anji E. |
|
|
22 |
5 |
p. 1311-1315 |
artikel |
5 |
Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers
|
Watcharananan, Siriorn P. |
|
|
22 |
5 |
p. 1459-1466 |
artikel |
6 |
Critical warm ischemia time point for cardiac donation after circulatory death
|
Sánchez-Cámara, Silvia |
|
|
22 |
5 |
p. 1321-1328 |
artikel |
7 |
Cross-decoration of dendritic cells by non-inherited maternal antigen-containing extracellular vesicles: Potential mechanism for PD-L1-based tolerance in cord blood and organ transplantation
|
Lema, Diego A. |
|
|
22 |
5 |
p. 1329-1338 |
artikel |
8 |
Deceased donor kidneys allocated out of sequence by organ procurement organizations
|
King, Kristen L. |
|
|
22 |
5 |
p. 1372-1381 |
artikel |
9 |
Differences between race-based and race-free estimated glomerular filtration rate among living kidney donors
|
Husain, Syed A. |
|
|
22 |
5 |
p. 1504-1505 |
artikel |
10 |
Enhanced autophagy alleviated corneal allograft rejection via inhibiting NLRP3 inflammasome activity
|
Wei, Chao |
|
|
22 |
5 |
p. 1362-1371 |
artikel |
11 |
High-density lipoprotein infusion protects from acute graft-versus-host disease in experimental allogeneic hematopoietic cell transplantation
|
Chagué, Cécile |
|
|
22 |
5 |
p. 1350-1361 |
artikel |
12 |
Humoral immune responses against SARS-CoV-2 in transplantation: Actionable biomarker or misplaced trust?
|
Fishman, Jay A. |
|
|
22 |
5 |
p. 1291-1292 |
artikel |
13 |
Impact of anastomosis time during lung transplantation on primary graft dysfunction
|
Vandervelde, Christelle M. |
|
|
22 |
5 |
p. 1418-1429 |
artikel |
14 |
Impact of ex vivo lung perfusion on brain-dead donor lung utilization: The French experience
|
Abdoul, Naïssa |
|
|
22 |
5 |
p. 1409-1417 |
artikel |
15 |
Importance of measuring glomerular filtration rate for candidates to living kidney donation
|
Gaillard, François |
|
|
22 |
5 |
p. 1494-1495 |
artikel |
16 |
Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial
|
Kaminski, Hannah |
|
|
22 |
5 |
p. 1430-1441 |
artikel |
17 |
Incidental peritoneal and hepatic lesions in a living kidney donor candidate
|
Mao, Rui-Min |
|
|
22 |
5 |
p. 1489-1491 |
artikel |
18 |
Mortality in solid organ transplant recipients with COVID-19: More than meets the eye
|
Maggiore, Umberto |
|
|
22 |
5 |
p. 1496-1497 |
artikel |
19 |
mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients
|
Netti, Giuseppe S. |
|
|
22 |
5 |
p. 1475-1482 |
artikel |
20 |
Nanotherapeutics in transplantation: How do we get to clinical implementation?
|
Plumblee, Leah |
|
|
22 |
5 |
p. 1293-1298 |
artikel |
21 |
New Organ Transport Support Technology is a Game Changer
|
Pullen, Lara C. |
|
|
22 |
5 |
p. 1285-1286 |
artikel |
22 |
Normothermic ex situ pancreas perfusion for the preservation of porcine pancreas grafts
|
Mazilescu, Laura I. |
|
|
22 |
5 |
p. 1339-1349 |
artikel |
23 |
Normothermic regional perfusion and US legal standards for determining death are not aligned
|
Glazier, Alexandra K. |
|
|
22 |
5 |
p. 1289-1290 |
artikel |
24 |
Organ repair and regeneration: Preserving organs in the regenerative medicine era
|
Wilks, Benjamin T. |
|
|
22 |
5 |
p. 1487-1488 |
artikel |
25 |
Outcome of liver transplantation with grafts from brain-dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors
|
Patrono, Damiano |
|
|
22 |
5 |
p. 1382-1395 |
artikel |
26 |
Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine
|
Charmetant, Xavier |
|
|
22 |
5 |
p. 1442-1450 |
artikel |
27 |
Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT)
|
Boster, Julia M. |
|
|
22 |
5 |
p. 1396-1408 |
artikel |
28 |
Proceedings from the metrics forum in heart transplantation for performance monitoring
|
Kobashigawa, Jon A. |
|
|
22 |
5 |
p. 1299-1306 |
artikel |
29 |
Reported cases of end-stage kidney disease—United States, 2000–2019
|
Ríos Burrows, Nilka |
|
|
22 |
5 |
p. 1483-1486 |
artikel |
30 |
Response to American College of Physician’s statement on the ethics of transplant after normothermic regional perfusion
|
Parent, Brendan |
|
|
22 |
5 |
p. 1307-1310 |
artikel |
31 |
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19
|
Werbel, William A. |
|
|
22 |
5 |
p. 1316-1320 |
artikel |
32 |
Successful kidney transplantation from a deceased donor with severe COVID-19 respiratory illness with undetectable SARS-CoV-2 in donor kidney and aorta
|
Lee, Kyungho |
|
|
22 |
5 |
p. 1501-1503 |
artikel |
33 |
The impact of machine perfusion of the heart on warm ischemia time and organ yield in donation after circulatory death
|
Feizpour, Cyrus A. |
|
|
22 |
5 |
p. 1451-1458 |
artikel |
34 |
True effect of monoclonal antibody for COVID-19 in kidney transplant recipients
|
Khatri, Akshay |
|
|
22 |
5 |
p. 1492-1493 |
artikel |
35 |
Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients
|
Bertrand, Dominique |
|
|
22 |
5 |
p. 1498-1500 |
artikel |